Serum Institute of India

The partnership aims to ensure access to a class of innovative therapies that have, to date, been out of reach in low- and…

The arrangement again provides an option to secure additional doses if the vaccines pillar of the Access to COVID-19 Tools…

CDX-005, an intranasal, live-attenuated vaccine candidate, has completed preclinical animal studies, and Codagenix expects to…

The DCGI has, however, put certain conditions like taking extra care during screening, providing additional information in…

Juilee Dandekar, Sector Expert - Healthcare, Business Research & Advisory, Aranca informs that with India Pharma Inc's…

Serum Institute will also manufacture the antigen component of the vaccine, dubbed NVX‑CoV2373

They call for more timely responses and accountability on part of both regulators and companies to ensure patient safety

The company took this step after the DCGI issued a show cause notice to the company for not informing it about AstraZeneca…

If DCGI has any safety concerns, we will follow their instructions and abide by the standard protocol, said SII in response to…

Beximco would be the exclusive supplier in Bangladesh for the vaccine being developed by SII